James A. Worth
17 IP cases indexed. Covers patent matters.
Cases Presided Over
17 cases indexed | Page 1 of 1
Zepp Health Corporation v.University of Connecticut
Zepp Health and the University of Connecticut settled their IPR dispute over Patent 10,278,647 B2. The Board granted a joint motion to terminate, ending the proceeding before trial.
EP Family Corp. v.Office Kick Inc.
EP Family Corp. and Office Kick, Inc. settled their dispute and jointly moved to terminate the IPR before any institution, resulting in a confidential settlement and dismissal of the proceedings.
ZEPP HEALTH CORPORATION v.Worcester Polytechnic Institute
Zepp Health filed an IPR against Worcester Polytechnic Institute’s patent 10,653,362. The parties settled the dispute before a trial, and the Board terminated the proceeding, keeping the settlement confidential.
TROVE BRANDS, LLC v.CamelBak Products, LLC
TROVE BRANDS successfully convinced the PTAB to institute an IPR against CamelBak Products' drinkware patent. The Board found a reasonable likelihood of prevailing on obviousness grounds (103) over prior art references including Nakajima and Ribarits. This decision sets up a detailed examination of complex mechanical features in beverage containers.
ITM Isotope Technologies Munich SE v.The Johns Hopkins University et al.
ITM Isotope Technologies Munich SE challenged The Johns Hopkins University's claims regarding FAP-α targeting moieties based on obviousness and patentability issues (103/112). The Board instituted the PGR, finding that the claims face significant challenges related to enablement and indefiniteness.
Charles River Laboratories, Inc. v.Seikagaku Corporation
Charles River Laboratories successfully petitioned to invalidate Seikagaku Corporation's patent claims related to endotoxin detection. The Board found grounds for invalidity under 35 U.S.C. § 102 and § 112, specifically citing anticipation by a prior publication.
Home Depot U.S.A., Inc. v.H2 Intellect LLC
Home Depot and H2 Intellect settled their post‑grant review of patent 12,056,736 B2. The Board terminated the proceeding before instituting trial and ordered the settlement agreement to remain confidential.
Trove Brands, LLC v.CamelBak Products, LLC
Trove Brands' IPR challenge against CamelBak Products regarding a drinkware patent was denied by the PTAB. The Board found that the Petitioner failed to establish a reasonable likelihood of prevailing on any ground, despite arguments concerning functional equivalence in user release mechanisms over prior art like Kiyota and Ribarits.
Integrated DNA Technologies, Inc. et al. v.Tecan Group AG
Integrated DNA Technologies challenged Tecan Genomics's NGS patent (9546399) on grounds of anticipation and obviousness over prior art references Iafrate and Kivioja. The PTAB instituted the IPR, finding a reasonable likelihood that at least one claim is unpatentable under 35 U.S.C. § 103 over Iafrate and Kivioja.
Integrated DNA Technologies, Inc. et al. v.Tecan Group AG
The PTAB instituted the IPR, finding a reasonable likelihood of unpatentability based on obviousness over Iafrate and Kivioja for key NGS claims. The Board also provided definitive claim constructions for 'indexing site' and 'identifier site.'
TROVE BRANDS, LLC v.CamelBak Products, LLC
The PTAB denied TROVE BRANDS' request to institute IPR against CamelBak Products regarding drinkware cap mechanisms. The Board found that the Petitioner failed to show a reasonable likelihood of unpatentability over combinations of prior art references like Kiyota, Choi, Park, and Ribarits.
Trove Brands, LLC v.CamelBak Products, LLC
Trove Brands' IPR petition against CamelBak Products regarding mouthpiece and cap assemblies was denied by the PTAB. The Board found that petitioner failed to meet the statutory threshold for institution, specifically rejecting obviousness grounds under 35 U.S.C. § 103.
Charles River Laboratories, Inc. v.Seikagaku Corporation
Charles River Laboratories successfully petitioned to institute IPR against Seikagaku Corporation's patent (11236318) based on grounds of lack of written description and obviousness. The Board found sufficient evidence at this preliminary stage, allowing the challenge to proceed into full litigation.
LifeVac, LLC v.DCStar Inc.
LifeVac, LLC's IPR petition against DCStar Inc. was denied by the PTAB after the Board found insufficient evidence of unpatentability. The decision hinged on a prior art challenge regarding an inventor-originated public disclosure (IDEAR) that predated one key reference.
Catalyst OrthoScience Inc. v.Shoulder Innovations, Inc.
The PTAB denied Catalyst OrthoScience's Post-Grant Review of Shoulder Innovations' reverse shoulder implant patent (12,023,254). The denial was based on the advanced stage and significant overlap with co-pending district court litigation.
EP Family Corp. v.Office Kick Inc.
EP Family Corp. and Office Kick Inc. settled their IPR dispute before trial, leading the PTAB to terminate the proceeding and keep the settlement confidential.
GE Healthcare Ltd. et al. v.The Johns Hopkins University et al.
GE Healthcare and Johns Hopkins University jointly moved to terminate IPR2025-00808 concerning patent 11,938,201. The Board granted the motion, ending the proceeding without prejudice and allowing future filing.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.